NGVT · Ingevity Corp · Documents

Jan 16

Current report 8-K

Financial results, Regulation FD disclosure

Dec 16

Current report 8-K

Director or officer change, or executive pay

Oct 30

Earnings call

Q3 2024 earnings call

Oct 30

Quarterly report 10-Q FY2024 Q3, ended Sep 30

Quarterly report for FY2024 Q3

Revenue $376.9M ▼ 15.5% Net loss $107.2M Diluted EPS -$2.95

Oct 29

Current report 8-K

Financial results

Oct 25

Current report 8-K Events of Oct 22

Charter or bylaw amendment, or fiscal year change

Oct 3

Current report 8-K Events of Oct 2

Director or officer change, or executive pay, Regulation FD disclosure

Aug 1

Earnings call

Q2 2024 earnings call

Aug 1

Quarterly report 10-Q FY2024 Q2, ended Jun 30

Quarterly report for FY2024 Q2

Revenue $390.6M ▼ 18.9% Net loss $283.7M Diluted EPS -$7.81

Jul 31

Current report 8-K Events of Jul 29

Exit or restructuring costs, Regulation FD disclosure

Jul 31

Current report 8-K

Financial results

Jul 8

Current report 8-K Events of Jul 1

Entered into a material agreement, Ended a material agreement, Regulation FD disclosure

Jul 1

Current report 8-K Events of Jun 26

Director or officer change, or executive pay

May 2

Earnings call

Q1 2024 earnings call

May 2

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Revenue $340.1M ▼ 13.4% Net loss $56M Diluted EPS -$1.54

May 1

Current report 8-K

Financial results

Apr 23

Current report 8-K

Shareholder vote results

Mar 22

Proxy statement DEFR14A

Proxy statement

Mar 14

Current report 8-K Events of Mar 12

Director or officer change, or executive pay

Mar 11

Proxy statement DEF 14A Meeting Apr 23, 2024

Proxy statement

Mar 11

Annual report to holders ARS

Annual report to holders

Mar 11

Proxy statement DEFA14A

Proxy statement

Mar 1

Proxy statement PRE 14A Meeting Apr 23, 2024

Proxy statement

Feb 22

Earnings call

Q4 2023 earnings call

Feb 22

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Revenue $1.69B ▲ 1.4% Net loss $5.4M Diluted EPS -$0.15

Feb 21

Current report 8-K

Financial results

Nov 2

Earnings call

Q3 2023 earnings call

Nov 2

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Revenue $446M ▼ 7.5% Net income $25.2M ▼ 66.6% Diluted EPS $0.69 ▼ 65.2%

Nov 1

Current report 8-K Events of Oct 30

Entered into a material agreement, Exit or restructuring costs, Regulation FD disclosure

Nov 1

Current report 8-K

Financial results

Aug 3

Earnings call

Q2 2023 earnings call

Aug 3

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Revenue $481.8M ▲ 14.7% Net income $35.5M ▼ 40.6% Diluted EPS $0.97 ▼ 37.0%

Aug 2

Current report 8-K

Financial results

May 4

Earnings call

Q1 2023 earnings call

May 4

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Revenue $392.6M ▲ 2.6% Net income $50.7M ▼ 16.6% Diluted EPS $1.35 ▼ 12.9%

May 3

Current report 8-K

Financial results

Apr 28

Current report 8-K Events of Apr 27

Shareholder vote results

Mar 24

Current report 8-K Events of Mar 20

Entered into a material agreement, Completed an acquisition or sale of assets

Mar 10

Proxy statement DEF 14A

Proxy statement

Mar 10

Annual report to holders ARS

Annual report to holders

Mar 10

Proxy statement DEFA14A

Proxy statement

Feb 28

Earnings call

Q4 2022 earnings call

Feb 28

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $1.67B ▲ 19.9% Net income $211.6M ▲ 79.2% Diluted EPS $5.50 ▲ 86.4%

Feb 27

Current report 8-K

Financial results

Feb 21

Current report 8-K Events of Feb 16

Director or officer change, or executive pay

Nov 3

Earnings call

Q3 2022 earnings call

Nov 3

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $482M ▲ 27.9% Net income $75.4M Diluted EPS $1.98

Nov 2

Current report 8-K

Financial results

Oct 3

Current report 8-K

Completed an acquisition or sale of assets, Regulation FD disclosure

Aug 3

Earnings call

Q2 2022 earnings call